Halozyme Therapeutics (HALO) Deferred Taxes (2012 - 2026)
Halozyme Therapeutics' (HALO) quarterly Deferred Taxes came in at -$3.4 million in Q1 2026, down 219.94% year-on-year from $2.9 million in Q1 2025, and down 120.44% on a QoQ basis from $16.8 million in Q4 2025.
Halozyme Therapeutics (HALO) Deferred Taxes (2012 - 2026) Analysis & Trends
Halozyme Therapeutics (HALO) has 10 years of Deferred Taxes data on file, last reported at -$3.4 million in Q1 2026.
- On a quarterly basis, Deferred Taxes fell 219.94% year-over-year to -$3.4 million in Q1 2026; TTM through Mar 2026 was -$6.9 million, a 291.32% decrease from a year earlier, with the FY2025 full-year figure at -$634000.0, down 19.17% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$3.4 million, down from $16.8 million in the prior quarter.
- Over the last five years, Deferred Taxes for HALO reached as high as $16.8 million in Q4 2025 and fell as low as -$27.4 million in Q3 2025.
- Historically, Deferred Taxes has averaged -$4.7 million across 5 years, with a median of -$3.9 million in 2023.
- On a YoY basis, Deferred Taxes climbed as much as 321.38% in 2025 and fell as far as 9267.81% in 2025.
- Year by year, Deferred Taxes stood at -$14.7 million in 2022, then soared by 35.79% to -$9.4 million in 2023, then jumped by 262.28% to $15.3 million in 2024, then increased by 9.65% to $16.8 million in 2025, then sank by 120.44% to -$3.4 million in 2026.
- Per Business Quant data, the three most recent Deferred Taxes figures were -$3.4 million in Q1 2026, $16.8 million in Q4 2025, and -$27.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -188,883.60 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Halozyme Therapeutics | 9.55 Bn | 9.23 Bn | 297.47 Mn | -3.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.43 Mn |
| Dec 31, 2025 | 16.77 Mn |
| Sep 30, 2025 | -27.35 Mn |
| Jun 30, 2025 | 7.09 Mn |
| Mar 31, 2025 | 2.86 Mn |
| Dec 31, 2024 | 15.29 Mn |
| Sep 30, 2024 | -292,000.00 |
| Jun 30, 2024 | -14.24 Mn |
| Mar 31, 2024 | -1.29 Mn |
| Dec 31, 2023 | -9.42 Mn |
| Sep 30, 2023 | -9.70 Mn |
| Jun 30, 2023 | -11.51 Mn |
| Mar 31, 2023 | -3.87 Mn |
| Dec 31, 2022 | -14.68 Mn |
| Sep 30, 2022 | -25.70 Mn |
| Jun 30, 2022 | 13.30 Mn |
| Mar 31, 2022 | -12.93 Mn |
| Dec 31, 2021 | 12.95 Mn |
| Sep 30, 2021 | 142.48 Mn |
| Jun 30, 2015 | -63,000.00 |